Review summary
Teaching objective: Primary care for a 35-year-old professional baseball player with a year of progressive weakness and loss of coordination: recognizing mixed upper and lower motor neuron signs, excluding mimics (MRI of the brain and cervical spine, blood tests, EMG and nerve conduction studies), and making the diagnosis of amyotrophic lateral sclerosis on the Gold Coast and revised El Escorial criteria; riluzole with liver test monitoring, genetic testing (tofersen only for an SOD1 variant) and edaravone discussed; a multidisciplinary ALS clinic tracking ALSFRS-R, forced vital capacity and weight; nutrition, speech and swallowing, mobility equipment, noninvasive ventilation thresholds, work accommodation, mood screening, and early advance care planning, on the AAN ALS practice parameters (1922).
Historical timeline
| Date | Event | Claims |
|---|---|---|
| June 19, 1903 | Born in Yorkville, Manhattan. | CLM-0001 |
| Winter of 1906 | Death of his sister Sophie. | CLM-0002 |
| February 1921 | Enrolled at Columbia University. | CLM-0003 |
| 1938 | First neurological symptoms; batting average fell to .295. | CLM-0005, CLM-0011 |
| May 2, 1939 | Took himself out of the lineup after 2,130 consecutive games. | CLM-0004 |
| June 19, 1939 | Diagnosis of amyotrophic lateral sclerosis certified at the Mayo Clinic. | CLM-0006 |
| July 4, 1939 | Retired from baseball on Lou Gehrig Appreciation Day. | CLM-0007 |
| October 1939 | Accepted appointment as a New York City Parole Commissioner. | CLM-0008 |
| June 2, 1941 | Died at home in the Bronx. | CLM-0009 |
| June 17, 2016 | Published discussion of the head-trauma hypothesis and the sealed records. | CLM-0010 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Henry Louis Gehrig was born on June 19, 1903, in the Yorkville section of Manhattan, New York, to Heinrich and Christina Gehrig, German immigrants. The birth date used for the synthetic date of birth. |
confirmed | Ray JL. Lou Gehrig supports |
| D | Three of his siblings died young: his sister Anna in September 1902 at about three months, his sister Sophie in the winter of 1906 of a combination of measles, diphtheria and bronchopneumonia, and a brother shortly after birth. Family history; the causes of Anna's and the infant brother's deaths are not recorded in the cited source. |
confirmed | Ray JL. Lou Gehrig supports |
| D | He enrolled at Columbia University on a football scholarship in February 1921. Social history. |
confirmed | Ray JL. Lou Gehrig supports |
| D | He played first base for the New York Yankees and, on May 2, 1939, in Detroit, took himself out of the lineup after a then-record 2,130 consecutive games. The anchor for the index date. PBS gives May 1, 1939; the Hall of Fame and SABR accounts of Detroit on May 2 are used. |
confirmed | Gehrig, Hunter and Frates each furthered cause of ALS cure supports Hall of Fame opened the day of Lou Gehrig's final game supports Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? supports |
| D | In 1938 he batted .295, the first time under .300 since 1925, and his hitting fell off sharply in midsummer; he had an attack of lumbago and a badly jammed thumb that season. In the winter of 1938 to 1939 he lost his strength and collapsed while ice skating, in spring training 1939 he collapsed while putting on his uniform pants and his reflexes had slowed alarmingly, and at 35 he batted .143 in the first games of the 1939 season. The anchor for the modern presenting problem: a year of progressive weakness and loss of coordination. |
confirmed | Ray JL. Lou Gehrig supports Gehrig, Hunter and Frates each furthered cause of ALS cure supports Hall of Fame opened the day of Lou Gehrig's final game supports |
| D | His first neurological symptoms began in 1938, around the time of his 35th birthday. The anchor for the onset of weakness in the modern episode. |
probable | Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? supports |
| D | He had repeated head injuries, including concussions, during his playing career. Recorded as history; the modern episode records a history of concussions without assuming any effect. |
probable | Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? supports |
| D | He was examined at the Mayo Clinic in Rochester, Minnesota, from June 13 to June 19, 1939, and on his 36th birthday his internist, Harold C. Habein, certified the diagnosis of amyotrophic lateral sclerosis; the clinic's statement added that he could continue in some executive activity. The anchor for the modern diagnosis; after the true-frame index date. The Hall of Fame spells the physician's name Hobein in one article. |
confirmed | Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? supports Gehrig, Hunter and Frates each furthered cause of ALS cure supports Ray JL. Lou Gehrig supports |
| D | He retired from baseball on July 4, 1939, when the Yankees held Lou Gehrig Appreciation Day before nearly 42,000 fans; in his speech he said that he considered himself "the luckiest man on the face of the earth." History only; after the true-frame index date. |
confirmed | Ray JL. Lou Gehrig supports Gehrig, Hunter and Frates each furthered cause of ALS cure supports Hall of Fame opened the day of Lou Gehrig's final game supports |
| D | In October 1939 he accepted Mayor La Guardia's appointment to a ten-year term as a New York City Parole Commissioner, was sworn in on January 2, 1940, and resigned quietly about a month before his death because his condition made the work impossible. The anchor for the modern work-accommodation theme (a desk role in public service); after the true-frame index date. |
confirmed | Ray JL. Lou Gehrig supports |
| D | He died at his home on Delafield Avenue in the Fieldston section of the Bronx on June 2, 1941, at 37. History only. PBS gives June 3, 1941. |
confirmed | Ray JL. Lou Gehrig supports Gehrig, Hunter and Frates each furthered cause of ALS cure supports Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? disputes |
| R | Researchers at the Boston University center for the study of traumatic encephalopathy have suggested that repetitive head trauma can cause a syndrome that mimics ALS, and that his repeated head injuries may have contributed to his decline; the Mayo Clinic has sealed his records, and it is not known whether an autopsy was performed. A retrospective hypothesis; the documented diagnosis remains ALS and the modern episode does not adopt the hypothesis. |
disputed | Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Progressive weakness and loss of coordination for about a year: fumbling with buttons and a bat, tripping on curbs, a fall on the ice in the winter, muscle cramps and twitching in the arms and thighs; no numbness, pain, double vision, or trouble speaking or swallowing. Examination: wasting of the hand muscles (left more than right), fasciculations in both arms and thighs, weakness of grip and of left ankle dorsiflexion, brisk reflexes with spread and a positive Hoffmann sign, normal sensation. Mixed upper and lower motor neuron signs; evaluation for motor neuron disease and its mimics begun, with neuromuscular neurology consultation booked | resolved | confirmed | active | CLM-0004, CLM-0005, CLM-0011 |
| S | Amyotrophic lateral sclerosis, limb onset: progressive weakness for about a year with upper and lower motor neuron signs in the cervical and lumbosacral regions, and active and chronic denervation on EMG in the cervical, thoracic and lumbosacral regions with normal sensory nerve conduction; MRI of the brain and cervical spine and blood tests exclude mimics. Meets the Gold Coast criteria and the revised El Escorial category of clinically probable ALS. ALSFRS-R 42 and FVC 88% of predicted at diagnosis. Synthetic modern episode linked to his documented diagnosis | active | confirmed | both_with_link | CLM-0006, CLM-0011 |
| S | Sprain of the left lateral ankle ligaments after tripping on a curb with left foot drop, while not wearing his ankle-foot orthosis: swelling and tenderness over the anterior talofibular ligament, able to bear weight, no bony tenderness by the Ottawa ankle rules; resolved | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1939-05-04 | Leukocytes [#/volume] in Blood by Automated count | 6.8 10*3/uL Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1939-05-04 | Hemoglobin [Mass/volume] in Blood | 15.2 g/dL Reference 13.2-17.1 g/dL |
http://loinc.org · 718-7 |
| S | 1939-05-04 | Platelets [#/volume] in Blood by Automated count | 245 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1939-05-04 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1939-05-04 | Potassium [Moles/volume] in Serum or Plasma | 4.4 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1939-05-04 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 1939-05-04 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1934)/1.73 sq M | 115 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1939-05-04 | Glucose [Mass/volume] in Serum or Plasma | 92 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1939-05-04 | Calcium [Mass/volume] in Serum or Plasma | 9.4 mg/dL Reference 8.6-10.3 mg/dL |
http://loinc.org · 17861-6 |
| S | 1939-05-04 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 32 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 1939-05-04 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 30 U/L Reference 10-40 U/L |
http://loinc.org · 1920-8 |
| S | 1939-05-04 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | 412 U/L (high) Reference 39-308 U/L |
http://loinc.org · 2157-6 |
| S | 1939-05-04 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 512 pg/mL Reference 232-1245 pg/mL |
http://loinc.org · 2132-9 |
| S | 1939-05-04 | Thyrotropin [Units/volume] in Serum or Plasma | 1.6 mIU/L Reference 0.45-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 1939-05-04 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.2% Reference Below 5.7% is normal; 5.7 to 6.4% prediabetes |
http://loinc.org · 4548-4 |
| S | 1939-05-04 | Forced vital capacity [Volume] Respiratory system | 4.62 L Reference >=4.1 L |
http://loinc.org · 19870-5 |
| S | 1939-05-04 | FVC measured/predicted | 90% Reference 80% of predicted or more is normal; noninvasive ventilation is considered below 50% |
http://loinc.org · 19872-1 |
| S | 1939-05-04 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | http://loinc.org · 55758-7 |
| S | 1939-05-18 | Forced vital capacity [Volume] Respiratory system | 4.52 L Reference >=4.1 L |
http://loinc.org · 19870-5 |
| S | 1939-05-18 | FVC measured/predicted | 88% Reference 80% of predicted or more is normal; noninvasive ventilation is considered below 50% |
http://loinc.org · 19872-1 |
| S | 1939-05-18 | Total score [ALSFRS-R] | 42 | http://loinc.org · 82953-1 |
| S | 1939-05-18 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | http://loinc.org · 44261-6 |
| S | 1939-06-29 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 1939-06-29 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 33 U/L Reference 10-40 U/L |
http://loinc.org · 1920-8 |
| S | 1939-06-29 | Forced vital capacity [Volume] Respiratory system | 4.31 L Reference >=4.1 L |
http://loinc.org · 19870-5 |
| S | 1939-06-29 | FVC measured/predicted | 84% Reference 80% of predicted or more is normal; noninvasive ventilation is considered below 50% |
http://loinc.org · 19872-1 |
| S | 1939-06-29 | Total score [ALSFRS-R] | 40 | http://loinc.org · 82953-1 |
| S | 1939-06-29 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | http://loinc.org · 44261-6 |
| S | 1939-08-24 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 35 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 1939-08-24 | Forced vital capacity [Volume] Respiratory system | 4.05 L (low) Reference >=4.1 L |
http://loinc.org · 19870-5 |
| S | 1939-08-24 | FVC measured/predicted | 79% (low) Reference 80% of predicted or more is normal; noninvasive ventilation is considered below 50% |
http://loinc.org · 19872-1 |
| S | 1939-08-24 | Total score [ALSFRS-R] | 38 | http://loinc.org · 82953-1 |
| S | 1939-08-24 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | http://loinc.org · 44261-6 |
| S | 1939-10-19 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 33 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 1939-10-19 | Forced vital capacity [Volume] Respiratory system | 3.69 L (low) Reference >=4.1 L |
http://loinc.org · 19870-5 |
| S | 1939-10-19 | FVC measured/predicted | 72% (low) Reference 80% of predicted or more is normal; noninvasive ventilation is considered below 50% |
http://loinc.org · 19872-1 |
| S | 1939-10-19 | Total score [ALSFRS-R] | 36 | http://loinc.org · 82953-1 |
| S | 1939-10-19 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | http://loinc.org · 44261-6 |
| S | 1939-07-20 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 41 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 1939-09-21 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | http://loinc.org · 55758-7 |
| S | 1939-09-21 | Total score [AUDIT-C] | 2 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1939-05-04 | Body height | 183 cm | 8302-2 | S |
| 1939-05-04 | Body weight | 89.5 kg | 29463-7 | S |
| 1939-05-04 | Body mass index (BMI) [Ratio] | 26.7 kg/m2 | 39156-5 | S |
| 1939-05-04 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 1939-05-04 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 1939-05-04 | Heart rate | 68 /min | 8867-4 | S |
| 1939-05-04 | Respiratory rate | 14 /min | 9279-1 | S |
| 1939-05-04 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1939-05-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1939-05-18 | Body height | 183 cm | 8302-2 | S |
| 1939-05-18 | Body weight | 89.2 kg | 29463-7 | S |
| 1939-05-18 | Body mass index (BMI) [Ratio] | 26.6 kg/m2 | 39156-5 | S |
| 1939-05-18 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 1939-05-18 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1939-05-18 | Heart rate | 70 /min | 8867-4 | S |
| 1939-05-18 | Respiratory rate | 14 /min | 9279-1 | S |
| 1939-05-18 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1939-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1939-06-29 | Body height | 183 cm | 8302-2 | S |
| 1939-06-29 | Body weight | 88.4 kg | 29463-7 | S |
| 1939-06-29 | Body mass index (BMI) [Ratio] | 26.4 kg/m2 | 39156-5 | S |
| 1939-06-29 | Systolic blood pressure | 120 mm[Hg] | 8480-6 | S |
| 1939-06-29 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1939-06-29 | Heart rate | 72 /min | 8867-4 | S |
| 1939-06-29 | Respiratory rate | 15 /min | 9279-1 | S |
| 1939-06-29 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1939-06-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1939-08-24 | Body height | 183 cm | 8302-2 | S |
| 1939-08-24 | Body weight | 87.4 kg | 29463-7 | S |
| 1939-08-24 | Body mass index (BMI) [Ratio] | 26.1 kg/m2 | 39156-5 | S |
| 1939-08-24 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 1939-08-24 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1939-08-24 | Heart rate | 74 /min | 8867-4 | S |
| 1939-08-24 | Respiratory rate | 16 /min | 9279-1 | S |
| 1939-08-24 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1939-08-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 1939-10-19 | Body height | 183 cm | 8302-2 | S |
| 1939-10-19 | Body weight | 86.6 kg | 29463-7 | S |
| 1939-10-19 | Body mass index (BMI) [Ratio] | 25.9 kg/m2 | 39156-5 | S |
| 1939-10-19 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 1939-10-19 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1939-10-19 | Heart rate | 76 /min | 8867-4 | S |
| 1939-10-19 | Respiratory rate | 16 /min | 9279-1 | S |
| 1939-10-19 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1939-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 1939-07-20 | Body height | 183 cm | 8302-2 | S |
| 1939-07-20 | Body weight | 88 kg | 29463-7 | S |
| 1939-07-20 | Body mass index (BMI) [Ratio] | 26.3 kg/m2 | 39156-5 | S |
| 1939-07-20 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 1939-07-20 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1939-07-20 | Heart rate | 74 /min | 8867-4 | S |
| 1939-07-20 | Respiratory rate | 15 /min | 9279-1 | S |
| 1939-07-20 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1939-07-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1939-09-21 | Body height | 183 cm | 8302-2 | S |
| 1939-09-21 | Body weight | 87 kg | 29463-7 | S |
| 1939-09-21 | Body mass index (BMI) [Ratio] | 26 kg/m2 | 39156-5 | S |
| 1939-09-21 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 1939-09-21 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1939-09-21 | Heart rate | 74 /min | 8867-4 | S |
| 1939-09-21 | Respiratory rate | 16 /min | 9279-1 | S |
| 1939-09-21 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1939-09-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Professional baseball player, a first baseman for New York for many seasons; studied at Columbia University; two days ago he took himself out of the lineup because of his weakness, ending a long run of consecutive games
- S Never smoked; one or two beers on some weekends; no other substance use
- S Lives with his wife in a house with stairs to the bedrooms; he chooses who comes to his visits and what they are told
- S Several concussions over his career, the last more than five years ago, without lasting symptoms
- S Strengths and supports: disciplined, steady and modest; used to training and working with a team; financially secure; a close household and many friends in the game
Functional status
- S Independent in all daily activities, but slow with buttons and laces; climbs stairs holding the rail; walks without an aid and trips on curbs now and then
Mental status
- S Alert, quiet and courteous; frustrated and worried by his loss of strength; PHQ-2 1
Allergies and medications
Allergies
- S No known allergy
Medications
- S Riluzole 50 mg oral tablet, one tablet by mouth twice daily, an hour before or two hours after meals
- S Ibuprofen 400 mg oral tablet, one tablet by mouth every 8 hours with food as needed for ankle pain, for up to 5 days
Procedures and immunizations
Procedures
- S Seated spirometry (forced vital capacity)
- S MRI of the brain
- S MRI of the cervical spine
- S Needle electromyography of four body regions
- S Motor and sensory nerve conduction studies of the arms and legs
- S Genetic testing for ALS-associated genes (SOD1, C9orf72 repeat, FUS, TARDBP and others), with genetic counseling
- S Advance care planning conversation, about 30 minutes
Immunizations
- S 1939-09-21: Influenza vaccine, 1939-1940 season (inactivated)
- S 1939-09-21: COVID-19 vaccine, 1939-1940 formula
- S 1939-09-21: Hepatitis B vaccine (HepB-CpG), first of two doses
- S 1939-10-19: Hepatitis B vaccine (HepB-CpG), second of two doses
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D 1938: Lumbago and a badly jammed thumb during the season (CLM-0005)
- D During his playing career: Repeated head injuries, including concussions (CLM-0012)
Family history
- D sister: Died in infancy at about three months; cause not recorded in the cited source
- D sister: Died in early childhood of measles, diphtheria and bronchopneumonia
- D brother: Died shortly after birth; cause not recorded in the cited source
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| A clear diagnosis, with mimics excluded, within four weeks | 1939-05-18 | completed | Diagnosis made at two weeks on EMG, MRI and blood tests |
| No falls, using an ankle-foot orthosis, a cane, and a safer home | 1939-10-19 | active | One fall with an ankle sprain in July, on a day the orthosis was not worn; no falls since it has been worn for all walking outdoors |
| Weight held within 5% of the weight at diagnosis | 1939-10-19 | completed | 89.2 kg at diagnosis and 86.6 kg at five months (2.9% lower) |
| Breathing tracked every visit, with noninvasive ventilation started as soon as criteria are met | 1939-10-19 | active | FVC 72% and no symptoms at five months; overnight oximetry ordered |
| Goals of care, a health care agent, and his wishes about ventilation and feeding recorded early and revisited | 1939-09-21 | completed | Agent named and wishes recorded at the preventive visit |
| Working in a role that suits him, with accommodations | 1939-10-19 | completed | Started a desk role in public service with accommodations |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Evaluation of progressive weakness with mixed upper and lower motor neuron signs: blood count, metabolic panel with calcium, creatine kinase, vitamin B12, TSH, A1c, serum protein electrophoresis with immunofixation, and an HIV test; MRI of the brain and cervical spine; seated spirometry | completed | GL-GOLDCOAST-2020, GL-ELESCORIAL-2000, GL-AAN-ALS-CARE-2009 |
| Neuromuscular neurology consultation with EMG and nerve conduction studies for progressive weakness with mixed upper and lower motor neuron signs | completed | GL-GOLDCOAST-2020, GL-AAN-ALS-CARE-2009 |
| Safety while the evaluation proceeds: no competitive play or heavy lifting, a physical therapy assessment of balance and gait, home fall precautions (night lights, rails, no loose rugs), and a same-day call for any trouble swallowing or breathing; results given to him first, in person | completed | GL-AAN-ALS-CARE-2009 |
| Riluzole 50 mg twice daily, with ALT monthly for the first 3 months and then every 3 months, and a blood count with any fever; genetic testing with genetic counseling for ALS-associated genes, with tofersen only if an SOD1 variant is found; edaravone discussed as an option with modest evidence in a selected group | completed | GL-AAN-ALS-DRUG-2009, GL-ALS-GENETICS-2023, GL-TOFERSEN-2022 |
| Multidisciplinary ALS clinic every 2 to 3 months (neurology, nursing, physical, occupational and speech therapy, nutrition, respiratory therapy, social work and mental health): ALSFRS-R, seated forced vital capacity and maximal inspiratory pressure, and weight at every visit; cognitive and behavioral screening; PHQ-9 | completed | GL-AAN-ALS-CARE-2009, GL-ALSFRSR-1999 |
| Respiratory plan: forced vital capacity and maximal inspiratory pressure every visit, supine capacity and overnight oximetry when values fall or symptoms appear; noninvasive ventilation when forced vital capacity is below 50% of predicted, maximal inspiratory pressure is weaker than -60 cmH2O, overnight oximetry shows desaturation, or orthopnea or morning headaches appear; influenza and COVID-19 vaccines | completed | GL-AAN-ALS-DRUG-2009, GL-CDC-IMZ-2026 |
| Nutrition, speech, swallowing and mobility: a high-calorie diet to keep weight stable, with gastrostomy discussed early, while forced vital capacity is above 50%; speech and swallowing assessments every visit and voice banking; a left ankle-foot orthosis, a cane, and an early power wheelchair evaluation because of lead times; home and car adaptations | completed | GL-AAN-ALS-DRUG-2009, GL-AAN-ALS-CARE-2009 |
| Work and planning: workplace accommodations for a desk role (accessible office, flexible hours, rest breaks, voice-recognition software, parking), information on disability benefits, social work support, and early advance care planning, revisited at each change | completed | GL-AAN-ALS-CARE-2009 |
Planned encounters
- 1939-05-04 — New patient with progressive weakness and loss of coordination: evaluation for a motor neuron disorder and its mimics, safety, and how he wants to receive results (ENC-001)
- 1939-05-18 — Neuromuscular neurology consultation with EMG and nerve conduction studies; results of MRI and blood tests; diagnosis and start of treatment (ENC-002)
- 1939-06-29 — Six weeks after diagnosis: riluzole safety, genetic test result, multidisciplinary ALS clinic, mobility, mood, and his decision about work (ENC-003)
- 1939-07-20 — Same-day sick visit for a left ankle sprain (ENC-006, unscheduled)
- 1939-08-24 — Three months after diagnosis: ALSFRS-R, breathing, weight, speech, mobility equipment, and work accommodations (ENC-004)
- 1939-09-21 — Periodic adult preventive visit (ENC-007)
- 1939-10-19 — Five months after diagnosis: breathing tests and noninvasive ventilation planning, nutrition and gastrostomy discussion, and his new desk work (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Sick Visit
- Progress note 05 — Focused Visit (Follow-up)
- Progress note 06 — Preventive Visit
- Progress note 07 — Focused Visit (Care-plan review)
- Neurology (neuromuscular) referral
- Neurology (neuromuscular) consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Sick Visit (XML)
- Progress note 05 — Focused Visit (Follow-up) (XML)
- Progress note 06 — Preventive Visit (XML)
- Progress note 07 — Focused Visit (Care-plan review) (XML)
- Neurology (neuromuscular) referral (XML)
- Neurology (neuromuscular) consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Ray JL. Lou Gehrig | Society for American Baseball Research (SABR) BioProject | biography |
| SRC-0002 | Gehrig, Hunter and Frates each furthered cause of ALS cure | National Baseball Hall of Fame and Museum | biography |
| SRC-0003 | Hall of Fame opened the day of Lou Gehrig's final game | National Baseball Hall of Fame and Museum | biography |
| SRC-0004 | Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? | PBS NewsHour | other |
| SRC-0005 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the mimic work-up, the EMG criteria (Gold Coast and revised El Escorial), riluzole liver monitoring, the decisions on edaravone and tofersen, the noninvasive ventilation thresholds, gastrostomy timing, and work accommodation. |
| provenance review | not_started | The SABR biography (Ray), two National Baseball Hall of Fame articles, and PBS NewsHour (Markel 2016) logged. The death date conflict (June 2 or 3, 1941) and the head-trauma hypothesis (R, disputed) are recorded. |
| safe messaging review | not_started | A progressive fatal illness: the modern episode screens mood at every visit (PHQ-9 below 10 throughout) and plans care early; his documented speech is quoted only as history; no decision, statement or health fact is attributed to his wife or other real people. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.